Artificial Intelligence – Page 3

AI-Driven Recognition of Disease Signatures in Cellular Pathway Visualizations

6 months ago talkbio0Tagged Artificial Intelligence, Cellular Pathway, disease signatures, Machine Learning, Neural Network Simulation, Transcriptomic Analysis, Visualizations

Artificial Intelligence (AI), Neural Networks, Disease Signatures, Cellular Pathway Visualizations, Transcriptomic Analysis, Machine Learning

Eli Lilly and insitro Collaborate on AI-Driven Metabolic Disease Therapies

7 months ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, Biotechnology, Drug Discovery, Eli, Eli Lilly, GalNAc, Insitro, Metabolic Diseases, pharmaceutical partnership, RNA, Small Interfering

Eli Lilly, insitro, AI, metabolic diseases, siRNA, GalNAc, drug discovery, biotechnology, pharmaceutical partnership

Eli Lilly and Insitro Collaborate on AI-Driven Therapies for Metabolic Diseases

7 months ago talkbio0Tagged Agreement, Antibody Therapy, Aortic Valve Insufficiency, Artificial Intelligence, Drug Development, Eli, Eli Lilly, Insitro, MASLD, Metabolic, Metabolic Diseases, RNA, Small Interfering, steatotic liver disease, strategic

Eli Lilly, Insitro, AI, Metabolic Diseases, Drug Development, Strategic Agreements, siRNA Therapies, Antibody Therapy, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Mendaera Secures $73M Series B Funding to Revolutionize Mainstream Medical Procedures with Robotics and AI

7 months ago talkbio0Tagged Artificial Intelligence, Healthcare technology, Medical procedure, Mendaera, Robotics, Series B, Threshold, Ventures

Mendaera, Series B funding, robotics, AI, medical procedures, healthcare technology, Threshold Ventures

Transforming Multiple Sclerosis Treatment: Emerging Trends and Future Directions

7 months ago talkbio0Tagged Artificial Intelligence, disease-modifying therapies, DNA Integration, Hemopoietic stem cell transplant, High-Efficacy, Multiple Sclerosis, myelin repair, neurorestorative, Precision Medicine

Multiple sclerosis, high-efficacy treatments, stem cell transplantation, disease-modifying therapies, personalized medicine, AI integration, myelin repair, neurorestorative therapies.

AI Guidance for Investors: Navigating the Future with Strategic Approaches and Regulatory Insights

7 months ago talkbio0Tagged Adoption, Advice, Artificial Intelligence, Computer Security, governance, Health care facility, investors, Mapping Strategies, Regulatory Impact, Risk, Strategic AI

AI Guidance for Investors, Strategic AI Adoption, Regulatory Impact on AI, Cybersecurity Risks in AI, AI Mapping Strategies, Data Governance in AI, Future of AI in Healthcare

Biopharma Leaders Navigate AI ‘Hype Cycle’: Bayer, Daiichi Sankyo, and argenx Share Insights on AI Implementation in Marketing

7 months ago talkbio0Tagged Argenx, Artificial Intelligence, Bayer, Biopharma, biopharma marketing, Daiichi, Implementation, Industry, Sankyo

AI in biopharma marketing, Bayer, Daiichi Sankyo, argenx, AI implementation, biopharma industry, AI hype cycle

Revolutionizing Drug Discovery: AI-Driven Solutions for Efficient and Personalized Treatments

7 months ago talkbio0Tagged Artificial Intelligence, Computation (action), Drug Development, Drug Discovery, Efficient, Identification (Psychology), Machine Learning, Machine Learning, Pharmaceutical Research, Precision Medicine, processes, QML, quantum, Quantum Machine Learning, Target, Validation

Artificial Intelligence (AI) in Drug Discovery, Machine Learning (ML) for Drug Development, Quantum Computing in Pharmaceutical Research, Personalized Medicine, Efficient Drug Discovery Processes, AI-Driven Target Identification and Validation, Quantum Machine Learning (QML) for Drug Discovery